This is incredible, Jeanne! Polling in our race that will decide Senate control finally has me gaining momentum. ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | This is incredible, Jeanne! Polling in our race that will decide Senate control finally has me gaining momentum. After months of trailing my Trump-endorsed opponent, Adam Laxalt (R), I'm now within just 1 point. At 6:00 p.m. tonight, my campaign manager and I have our most important meeting of this election – we're locking in final investments that we MUST make to take the lead. But my team just pulled our finance report, and we're $30,575 short ahead of our quarterly FEC fundraising goal. If we hit this goal, we'll be able to execute our strategy and win; if we fall short, we'll have to cancel make-or-break investments and our chances will collapse. | It's true what The Washington Post reported: The GOP is "most bullish" about flipping Nevada red – because it is the ONE seat they can flip to hand Senate control back to Mitch McConnell. That's why McConnell and his allies are spending $38 million on attack ads to defeat me, and far-right extremists like Donald Trump and Ted Cruz keep coming to Nevada to attack me. Fortunately, a group of generous Democratic donors are TRIPLING every dollar up to $150,000 to help me reach my fundraising goal before our FINAL quarterly FEC deadline. Jeanne, tonight's meeting at 6:00 p.m. will be THE most important of this election. Will you please rush a TRIPLE-MATCHED donation of $5 (becomes $15) to make sure we have the resources we need to win and keep Nevada and the Senate blue? | If you've saved payment information with ActBlue Express, your donation will go through immediately: | I really appreciate you stepping up at this critical moment, Jeanne. Catherine | | | | | | |
No comments:
Post a Comment